NAAA and hemophagocytic syndrome: We designed and initiated a single‐arm clinical trial (phase Ib) to evaluate the simultaneous administration of dexamethasone and cyclosporine with anti‐CD41‐PLT‐VP16 in HLH patients (reference number: 3923‐435‐02).